Senesco Technologies Inc. is negotiating an exclusive deal outside the U.S. that would generate $35 million for the New Brunswick, N.J.-based company. (BioWorld Today)
Senesco Technologies Inc. is negotiating an exclusive deal outside the U.S. that would generate $35 million for the New Brunswick, N.J.-based company. (BioWorld Today)
It appears that Amgen Inc. could fall victim to a government reimbursement program that calls its anemia drug Aranesp "functionally equivalent" to a similar product, Procrit, made by Johnson & Johnson. (BioWorld Today)
It appears that Amgen Inc. could fall victim to a government reimbursement program that calls its anemia drug Aranesp "functionally equivalent" to a similar product, Procrit, made by Johnson & Johnson. (BioWorld Today)
